Rescuing calcium ion homeostasis extended mouse lifespan
DIRECT ANSWER: Rescuing calcium ion homeostasis with the antidepressant mianserin significantly extended median and maximum lifespan in both progeroid and naturally aging mice, according to a Nature Communications study. Scientists linked disrupted Ca²⁺ signaling to S100A6 buildup, DNA damage, and inflammation—and showed restoring balance slowed aging even when treatment began late in life.
Key Takeaways
- Disrupted Ca²⁺ homeostasis drives aging through elevated cytoplasmic S100A6, PARP1 loss, and inflammatory chromatin fragments.
- Mianserin extended median survival by about 30% in progeroid mice and 17.5% in naturally aged mice.
- Benefits included better cardiac, pulmonary, and muscle function, with gains even after late-life dosing.
- The study used small all-male cohorts, so results need replication before human conclusions.
- Broken calcium handling is already implicated in sarcopenia and other age-related diseases.
Chinese researchers published findings in Nature Communications that connect a concrete molecular chain from calcium dysregulation to cellular aging. The work bridges a long-standing observation—that Ca²⁺ homeostasis fails in many age-related disorders—with a testable intervention in live animals.
Why does disrupted calcium homeostasis accelerate aging?
Cells rely on calcium ions to switch pathways on and off. In Hutchinson-Gilford progeria syndrome and normal aging, cytoplasmic Ca²⁺ rises while stores in the endoplasmic reticulum fall.
Proteomics on progeroid mouse lung tissue flagged the calcium pathway and the binding protein S100A6. S100A6 was elevated across heart, lung, skin, and muscle, and in patient fibroblasts. Knocking it down reduced DNA damage and senescence markers while restoring cell division.
The leak traced to IP3R, an overexpressed ER calcium channel. S100A6 partners with PARP1, a DNA-repair enzyme depleted in progeria. Excess S100A6 promotes PARP1 degradation, leading to DNA breaks and cytoplasmic chromatin fragments that fire the cGAS-STING inflammatory pathway.
How did mianserin rescue calcium signaling in mice?
Blocking IP3R with 2-APB extended progeroid median survival by 14.15% but caused tremors, ruling out long-term use. The team turned to mianserin, an established antidepressant that antagonizes serotonin receptors linked to IP3R activation.
In cells, mianserin reversed senescence markers, cut DNA damage, and reduced chromatin fragments. Artificially raising intracellular Ca²⁺ wiped out those anti-aging effects, supporting a calcium-specific mechanism.
In progeroid mice treated from four weeks, mianserin extended median survival by roughly 30% and improved weight, cardiac, pulmonary, and muscle function. In naturally aged mice given the drug every other day for four months, median survival rose 17.5%, with glossier fur, less spinal curvature, slower weight loss, and better locomotion.
What caveats should longevity researchers note?
The lifespan cohorts were tiny—seven or eight mice per group—and entirely male. Control mice also lived shorter than typical C57BL/6J averages, a recurring issue in rodent longevity work.
Healthspan measures nonetheless pointed the same way, suggesting genuine aging slowdown rather than a statistical fluke. Still, the field will need larger, mixed-sex replications before drawing human parallels. For broader context on aging science, see our Longevity & Biohacking coverage.
Does calcium aging biology connect to muscle and bone loss?
The Nature Communications authors note that Ca²⁺ homeostasis breaks down in sarcopenia, among other age-related diseases. Separate UK Biobank research shows sarcopenia and osteoporosis frequently travel together, sharing genes, biomarkers, and inflammatory links—though that analysis could not prove causality.
Together, the studies hint that calcium signaling may sit upstream of multiple frailty phenotypes. Mianserin is not a proven human geroprotector, but rescuing calcium ion homeostasis now has mammalian proof of concept—and a familiar drug candidate to test next.